Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 9, 2026Heart Failure Reviews

Early arrhythmia control improves outcomes in potentially reversible tachycardia-induced cardiomyopathy.

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Key result

Tachycardia-induced cardiomyopathy is an underrecognized, potentially reversible cause of heart failure requiring early identification and arrhythmia control to improve outcomes.

Authors

NSN Sato

Discussion

Loading...

Member takes

Overview

TIC diagnosis and management remain challenging in practice; leaves open key evidence gaps for optimal strategies.

Key Points

  • This review aims to clarify the historical development, mechanisms, and management challenges of tachycardia-induced cardiomyopathy.
  • Comprehensive review of historical and contemporary literature on tachycardia-induced cardiomyopathy.
  • Discussion of mechanistic insights involving neurohormonal activation and cellular dysfunction.
  • Analysis of current gaps in diagnosis and management strategies.
  • Tachycardia-induced cardiomyopathy is increasingly recognized but often remains undiagnosed in clinical settings.
  • Evidence suggests both persistent tachycardia and high arrhythmic burden lead to myocardial dysfunction.
  • Significant challenges exist due to a lack of specific diagnostic markers and optimal management evidence.

PICO

P
Population
Tachycardia-induced cardiomyopathy

Tachycardia-induced cardiomyopathy is a potentially reversible cause of heart failure requiring early identification and arrhythmia control, though specific diagnostic markers and optimal management strategies remain to be established.

Limitations

  • Mechanisms underlying incomplete recovery of cardiac function are not fully elucidated
  • Lack of specific diagnostic markers
  • Limited evidence for optimal management strategies
  • Mechanisms underlying TIC/AiCM and incomplete recovery of cardiac function in humans have not yet been fully elucidated

Cite This Study

N Sato (2026) conducted a review in Tachycardia-induced cardiomyopathy. Tachycardia-induced cardiomyopathy is an underrecognized, potentially reversible cause of heart failure requiring early identification and arrhythmia control to improve outcomes.

synapsesocial.com/papers/6a4f3dcd2b81a944af575e1ahttps://doi.org/10.1007/s10741-026-10650-2
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Beyond Tachycardia-Induced Cardiomyopathy2025
  2. 2Tachycardia induced cardiomyopathy as a hidden cause of Heart failure in Pediatrics; A retrospective single-centre study2024
  3. 3Takotsubo Cardiomyopathy–Induced Conduction System Quiescence With Concomitant Fascicular Ventricular Tachycardia and Complete Heart Block2026
  4. 4Long‐term prognosis of pure and impure tachycardiomyopathy2025
  5. 5Diagnostic Challenges in Takotsubo Syndrome: Bridging Mimics, Mechanisms, and Management2026 · 1 citations